Skip to main content
EVH logo

EVH · Evolent Health, Inc. · Analyst Estimates

Track EVH — free
$3.90 +0.47 (+13.70%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$441.11M
Shares
113.11M
Volume · Nov 20 4.42M Avg daily vol (3M) 2.16M

Analyst Estimates

Compare analyst forecasts for Evolent Health, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians. An EPS figure names its accounting basis, GAAP or Non-GAAP, where the capture records one, and compares only with the company's EPS on that basis; without one, the basis is not recorded.

Captured 2026-11-20 11:01 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.20
0.23
0.27
10
0.24
0.20
0.20
0.19
0
0
2
2
Revenue
USD
Publication date not stated
2.61B
2.64B
2.68B
14
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.28
0.42
0.59
9
0.43
0.40
0.39
0.39
0
0
1
1
Revenue
USD
Publication date not stated
3.13B
3.31B
3.55B
14
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.13
0.17
0.21
10
0.17
0.15
0.15
0.15
0
0
2
2
Revenue
USD
Publication date not stated
733.40M
768.14M
808.73M
14
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.01
0.068
0.13
6
0.072
0.072
0.072
0.062
0
2
1
1
Revenue
USD
Publication date not stated
688.15M
794.54M
893.03M
9
— — — — — — — —
Key facts CIK 1628908 CUSIP 30050B101 13F (30d) 212 filings 189 filers Visit website Investor relations